Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Oxford Nanopore gets Oracle backing for IPO

Published 16/09/2021, 07:26
Updated 16/09/2021, 07:30
© Reuters.

LONDON (Reuters) - British life sciences company Oxford Nanopore said on Thursday that U.S. tech company Oracle is to buy 150 million pounds ($207.38 million)of new shares at its upcoming initial public offering in London.

Oracle Corporation (NYSE:ORCL) will subscribe to the shares at the offer price as part of a collaboration agreement between the two companies. Oxford Nanopore said it is expected to sell 300 million pounds of new shares in total as well as stock held by some existing shareholders, in a listing that aims to build on the 2.4 billion pound valuation it achieved in its last funding round.

($1 = 0.7233 pounds)

($1 = 0.7233 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.